| 1B6J | A:1-99; B:101-199 | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 |
| 1B6K | A:1-99; B:101-199 | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5 |
| 1B6L | A:1-99; B:101-199 | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4 |
| 1B6M | A:1-99; B:101-199 | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6 |
| 1B6P | A:1-99; B:101-199 | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 |
| 1C6X | A:1-99; B:201-299 | ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. |
| 1C6Y | A:1-99; B:201-299 | ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. |
| 1C6Z | A:1-99; B:201-299 | ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. |
| 1C70 | A:1-99; B:201-299 | ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. |
| 1HBV | A:1-99; B:1-99 | A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC |
| 1HSG | A:1-99; B:1-99 | CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES |
| 1HSH | A:1-99; B:1-99; C:1-99; D:1-99 | CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES |
| 1HVC | A:1A-99A; A:1B-99B | CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR |
| 1K6C | A:1-99; B:1-99 | LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE |
| 1K6P | A:1-99; B:1-99 | LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE |
| 1K6T | A:1-99; B:1-99 | LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE |
| 1K6V | A:1-99; B:1-99 | LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE |
| 1KJ4 | A:1-99; B:1-99; C:1-99; D:1-99 | SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
| 1KJ7 | A:1-99; B:1-99 | SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
| 1KJF | A:1-99; B:1-99 | SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
| 1KJG | A:1-99; B:1-99 | SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
| 1KJH | A:1-99; B:1-99 | SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES |
| 1N49 | A:1-99; B:1-99; C:1-99; D:1-99 | VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY |
| 1NPA | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP |
| 1NPV | A:1-99; B:201-299 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271 |
| 1NPW | A:1-99; B:201-299 | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479 |
| 1ODW | A:1-99; B:1-99 | NATIVE HIV-1 PROTEINASE |
| 1ODX | A:1-99; B:1-99 | HIV-1 PROTEINASE MUTANT A71T, V82A |
| 1RL8 | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV-1 PROTEASE(V82A MUTANT) WITH RITONAVIR |
| 1RPI | A:1-99; B:1-99 | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY |
| 1RQ9 | A:1-99; B:1-99 | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY |
| 1RV7 | A:1-99; B:1-99 | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY |
| 1SDT | A:1-99; B:101-199 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SDU | A:1-99; B:101-199 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SDV | A:1-99; B:101-199 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SP5 | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS |
| 1T3R | A:1-99; B:1-99 | HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR |
| 1T7I | A:1-99; B:1-99 | THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. |
| 1T7J | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF INHIBITOR AMPRENAVIR IN COMPLEX WITH A MULTI-DRUG RESISTANT VARIANT OF HIV-1 PROTEASE (L63P/V82T/I84V) |
| 1T7K | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA |
| 1TCX | A:1-99; B:1-99 | HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386 |
| 1TW7 | A:1-99; B:1-99 | WIDE OPEN 1.3A STRUCTURE OF A MULTI-DRUG RESISTANT HIV-1 PROTEASE REPRESENTS A NOVEL DRUG TARGET |
| 1U8G | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2 |
| 1XL2 | A:1-99; B:1-99 | HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE |
| 1XL5 | A:1-99; B:1-99 | HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE |
| 1YT9 | A:1-99; B:1-99 | HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND |
| 1ZTZ | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX |
| 2A1E | A:1-99; B:1-99 | HIGH RESOLUTION STRUCTURE OF HIV-1 PR WITH TS-126 |
| 2A4F | A:1-99; B:1-99 | SYNTHESIS AND ACTIVITY OF N-AXYL AZACYCLIC UREA HIV-1 PROTEASE INHIBITORS WITH HIGH POTENCY AGAINST MULTIPLE DRUG RESISTANT VIRAL STRAINS. |
| 2AOF | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P1-P6 |
| 2AVO | A:1-99; B:1-99 | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S |
| 2AVS | A:1-99; B:1-99 | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S |
| 2AVV | A:1-99; B:1-99; D:1-99; E:1-99 | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S |
| 2BB9 | A:1-99; B:201-299 | STRUCTURE OF HIV1 PROTEASE AND AKC4P_133A COMPLEX. |
| 2BBB | A:1-99; B:201-299 | STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX. |
| 2BPV | A:1-99; B:1-99 | HIV-1 PROTEASE-INHIBITOR COMPLEX |
| 2BPW | A:1-99; B:1-99 | HIV-1 PROTEASE-INHIBITOR COMPLEX |
| 2BPX | A:1-99; B:1-99 | HIV-1 PROTEASE-INHIBITOR COMPLEX |
| 2BPY | A:1-99; B:1-99 | HIV-1 PROTEASE-INHIBITOR COMPLEX |
| 2BPZ | A:1-99; B:1-99 | HIV-1 PROTEASE-INHIBITOR COMPLEX |
| 2FXD | A:1-99; B:1-99 | X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE IRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632) |
| 2FXE | A:1-99; B:1-99 | X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE CRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632) |
| 2HB3 | A:1-99; B:1-99 | WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR GRL06579 |
| 2HS1 | A:1-99; B:101-199 | ULTRA-HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE V32I MUTANT WITH TMC114 (DARUNAVIR) INHIBITOR |
| 2HS2 | A:1-99; B:101-199 | CRYSTAL STRUCTURE OF M46L MUTANT OF HIV-1 PROTEASE COMPLEXED WITH TMC114 (DARUNAVIR) |
| 2I4D | A:1-99; B:201-299 | CRYSTAL STRUCTURE OF WT HIV-1 PROTEASE WITH GS-8373 |
| 2I4U | A:1-99; B:201-299 | HIV-1 PROTEASE WITH TMC-126 |
| 2I4V | A:1-99; B:201-299 | HIV-1 PROTEASE I84V, L90M WITH TMC126 |
| 2I4W | A:1-99; B:201-299 | HIV-1 PROTEASE WT WITH GS-8374 |
| 2I4X | A:1-99; B:201-299 | HIV-1 PROTEASE I84V, L90M WITH GS-8374 |
| 2IDW | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
| 2IEN | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
| 2IEO | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
| 2NMW | | [entry was replaced by entry 3OXC without any CATH domain information] |
| 2NMY | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR |
| 2NMZ | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR |
| 2NNK | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR |
| 2NNP | A:1-99; B:101-199 | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR |
| 2NPH | A:1-99; B:1001-1099 | CRYSTAL STRUCTURE OF HIV1 PROTEASE IN SITU PRODUCT COMPLEX |
| 2P3A | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE B HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR |
| 2P3B | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR |
| 2P3C | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF THE SUBTYPE F WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR |
| 2PQZ | A:1-99; B:1-99 | HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE-BASED INHIBITOR |
| 2ZYE | A:1-99; B:101-199 | STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY NEUTRON CRYSTALLOGRAPHY |
| 3A2O | A:1-99; B:101-199 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH KNI-1689 |
| 3BVA | A:1-99; B:1-99 | CYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND P2-NC ANALOG INHIBITOR |
| 3BVB | A:1-99; B:1-99 | CYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND INHIBITOR DARUNAVIR |
| 3CYX | A:1-99; B:1-99 | CRYSTAL STRUCTURE OF HIV-1 MUTANT I50V AND INHIBITOR SAQUINAVIRA |
| 3FX5 | A:1-99; B:101-199 | STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY HIGH RESOLUTION X-RAY CRYSTALLOGRAPHY |
| 3GGA | A:1-99; B:1-99; C:1-99; D:1-99; G:1-99; H:1-99 | HIV PROTEASE INHIBITORS WITH PSEUDO-SYMMETRIC CORES |
| 3GGV | A:1-99; B:1-99; C:1-99; D:1-99; E:1-99; F:1-99; G:1-99; H:1-99; I:1-99 | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS |
| 3GGX | A:1-99; F:1-99; G:1-99; H:1-99; B:1-99; C:1-99; D:1-99; E:1-99 | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS |
)
)